Director's Dealing • Jun 15, 2023
Director's Dealing
Open in ViewerOpens in native device viewer
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Nigel McCracken | ||
| 2 | Reason for the notification | |||
| a) | Position/status | CSO, primary insider | ||
| b) | Initial | Initial notification | ||
| notification/Amendment | ||||
| 3 | Details of issuer | |||
| a) | Name | BerGenBio ASA | ||
| b) | LEI | 213800TYYFXKYF3V2A23 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument Identification code |
Shares in BerGenBio ASA (ISIN NO0010650013). | ||
| b) | Nature of the transaction | Allocated offer shares in the rights issue of BerGenBio ASA. | ||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| 0.10 | 285,108 | |||
| d) | Aggregated information | |||
| — Aggregated volume |
285,108 shares for NOK 28,510.8. | |||
| — Price |
||||
| e) | Date of the transaction | 2023-06-14 | ||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Nigel McCracken | ||
| 2 | Reason for the notification | |||
| a) | Position/status | CSO, primary insider | ||
| b) | Initial notification/Amendment |
Initial notification | ||
| 3 | Details of issuer | |||
| a) | Name | BerGenBio ASA | ||
| b) | LEI | 213800TYYFXKYF3V2A23 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument Identification code |
Warrants (ISIN NO0012921495). | ||
| b) | Nature of the transaction | Receipt/accept of warrants (ISIN NO0012921495) to shares in BerGenBio ASA (ISIN NO0010650013). |
||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| 0 | 142,554 | |||
| d) | Aggregated information | |||
| — Aggregated volume |
142,554 warrants for NOK 0. | |||
| — Price |
||||
| e) | Date of the transaction | 2023-06-14 | ||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | James Barnes | ||
| 2 | Reason for the notification | |||
| a) | Position/status | COO, primary insider | ||
| b) | Initial notification/Amendment |
Initial notification | ||
| 3 | Details of issuer | |||
| a) | Name | BerGenBio ASA | ||
| b) | LEI | 213800TYYFXKYF3V2A23 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument Identification code |
Shares in BerGenBio ASA (ISIN NO0010650013). | ||
| b) | Nature of the transaction | Allocated offer shares in the rights issue of BerGenBio ASA. | ||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| 0.10 | 259,190 | |||
| d) | Aggregated information | |||
| — Aggregated volume |
259,190 shares for NOK 25,919. | |||
| — Price |
||||
| e) | Date of the transaction | 2023-06-14 | ||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | James Barnes | ||
| 2 | Reason for the notification | |||
| a) | Position/status | COO, primary insider | ||
| b) | Initial notification/Amendment |
Initial notification | ||
| 3 | Details of issuer | |||
| a) | Name | BerGenBio ASA | ||
| b) | LEI | 213800TYYFXKYF3V2A23 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument Identification code |
Warrants (ISIN NO0012921495). | ||
| b) | Nature of the transaction | Receipt/accept of warrants (ISIN NO0012921495) to shares in BerGenBio ASA (ISIN NO0010650013). |
||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| 0 | 129,595 | |||
| d) | Aggregated information — Aggregated volume — Price |
129,595 warrants for NOK 0. | ||
| e) | Date of the transaction | 2023-06-14 | ||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Martin Olin | ||
| 2 | Reason for the notification | |||
| a) | Position/status | CEO, primary insider | ||
| b) | Initial notification/Amendment |
Initial notification | ||
| 3 | Details of issuer | |||
| a) | Name | BerGenBio ASA | ||
| b) | LEI | 213800TYYFXKYF3V2A23 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument Identification code |
Shares in BerGenBio ASA (ISIN NO0010650013). | ||
| b) | Nature of the transaction | Allocated offer shares in the rights issue of BerGenBio ASA. | ||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| 0.10 | 2,000,000 | |||
| d) | Aggregated information | |||
| — Aggregated volume |
2,000,000 shares for NOK 200,000. | |||
| — Price |
||||
| e) | Date of the transaction | 2023-06-14 | ||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Martin Olin | ||
| 2 | Reason for the notification | |||
| a) | Position/status | CEO, primary insider | ||
| b) | Initial notification/Amendment |
Initial notification | ||
| 3 | Details of issuer | |||
| a) | Name | BerGenBio ASA | ||
| b) | LEI | 213800TYYFXKYF3V2A23 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument Identification code |
Warrants (ISIN NO0012921495). | ||
| b) | Nature of the transaction | Receipt/accept of warrants (ISIN NO0012921495) to shares in BerGenBio ASA (ISIN NO0010650013). |
||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| 0 | 1,000,000 | |||
| d) | Aggregated information | |||
| — Aggregated volume |
1,000,000 warrants for NOK 0. | |||
| — Price |
||||
| e) | Date of the transaction | 2023-06-14 | ||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Rune Skeie | ||
| 2 | Reason for the notification | |||
| a) | Position/status | CFO, primary insider | ||
| b) | Initial | Initial notification | ||
| notification/Amendment | ||||
| 3 | Details of issuer | |||
| a) | Name | BerGenBio ASA | ||
| b) | LEI | 213800TYYFXKYF3V2A23 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument Identification code |
Shares in BerGenBio ASA (ISIN NO0010650013). | ||
| b) | Nature of the transaction | Allocated offer shares in the rights issue of BerGenBio ASA. | ||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| 0.10 | 259,190 | |||
| d) | Aggregated information | |||
| — Aggregated volume |
259,190 shares for NOK 25,919. | |||
| — Price |
||||
| e) | Date of the transaction | 2023-06-14 | ||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Rune Skeie | ||
| 2 | Reason for the notification | |||
| a) | Position/status | CFO, primary insider | ||
| b) | Initial notification/Amendment |
Initial notification | ||
| 3 | Details of issuer | |||
| a) | Name | BerGenBio ASA | ||
| b) | LEI | 213800TYYFXKYF3V2A23 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument Identification code |
Warrants (ISIN NO0012921495). | ||
| b) | Nature of the transaction | Receipt/accept of warrants (ISIN NO0012921495) to shares in BerGenBio ASA (ISIN NO0010650013). |
||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| 0 | 129,595 | |||
| d) | Aggregated information — Aggregated volume — Price |
129,595 warrants for NOK 0. | ||
| e) | Date of the transaction | 2023-06-14 | ||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Anders Tullgren | ||
| 2 | Reason for the notification | |||
| a) | Position/status | Chairman of the Board of Directors, primary insider | ||
| b) | Initial notification/Amendment |
Initial notification | ||
| 3 | Details of issuer | |||
| a) | Name | BerGenBio ASA | ||
| b) | LEI | 213800TYYFXKYF3V2A23 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument Identification code |
Shares in BerGenBio ASA (ISIN NO0010650013). | ||
| b) | Nature of the transaction | Allocated offer shares in the rights issue of BerGenBio ASA. | ||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| 0.10 | 1,409,820 | |||
| d) | Aggregated information — Aggregated volume — Price |
1,409,820 shares for NOK 140,982. | ||
| e) | Date of the transaction | 2023-06-14 | ||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Anders Tullgren | ||
| 2 | Reason for the notification | |||
| a) | Position/status | Chairman of the Board of Directors, primary insider | ||
| b) | Initial notification/Amendment |
Initial notification | ||
| 3 | Details of issuer | |||
| a) | Name | BerGenBio ASA | ||
| b) | LEI | 213800TYYFXKYF3V2A23 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument Identification code |
Warrants (ISIN NO0012921495). | ||
| b) | Nature of the transaction | Receipt/accept of warrants (ISIN NO0012921495) to shares in BerGenBio ASA (ISIN NO0010650013). |
||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| 0 | 704,910 | |||
| d) | Aggregated information | |||
| — Aggregated volume |
704,910 warrants for NOK 0. | |||
| — Price |
||||
| e) | Date of the transaction | 2023-06-14 | ||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Svev AS | ||
| 2 | Reason for the notification | |||
| a) | Position/status | Closely associated person of primary insider Sveinung Hole, board member in BerGenBio ASA. |
||
| b) | Initial notification/Amendment |
Initial notification | ||
| 3 | Details of issuer | |||
| a) | Name | BerGenBio ASA | ||
| b) | LEI | 213800TYYFXKYF3V2A23 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument Identification code |
Shares in BerGenBio ASA (ISIN NO0010650013). | ||
| b) | Nature of the transaction | Allocated offer shares in the rights issue of BerGenBio ASA | ||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| 0.10 | 2,000,000 | |||
| d) | Aggregated information — Aggregated volume — Price |
2,000, 000 shares for NOK 200,000. | ||
| e) | Date of the transaction | 2023-06-14 | ||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Svev AS | ||
| 2 | Reason for the notification | |||
| a) | Position/status | BerGenBio ASA. | Closely associated person of primary insider Sveinung Hole, board member in | |
| b) | Initial notification/Amendment |
Initial notification | ||
| 3 | Details of issuer | |||
| a) | Name | BerGenBio ASA | ||
| b) | LEI | 213800TYYFXKYF3V2A23 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument Identification code |
Warrants (ISIN NO0012921495). | ||
| b) | Nature of the transaction | Receipt/accept of warrants (ISIN NO0012921495) to shares in BerGenBio ASA (ISIN NO0010650013) |
||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| 0 | 1,000,000 | |||
| d) | Aggregated information — Aggregated volume — Price |
1,000,000 warrants for NOK 0. | ||
| e) | Date of the transaction | 2023-06-14 | ||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Sally Bennett | ||
| 2 | Reason for the notification | |||
| a) | Position/status | Board member, primary insider | ||
| b) | Initial notification/Amendment |
Initial notification | ||
| 3 | Details of issuer | |||
| a) | Name | BerGenBio ASA | ||
| b) | LEI | 213800TYYFXKYF3V2A23 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument Identification code |
Shares in BerGenBio ASA (ISIN NO0010650013). | ||
| b) | Nature of the transaction | Allocated offer shares in the rights issue of BerGenBio ASA. | ||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| 0.10 | 314,826 | |||
| d) | Aggregated information | |||
| — Aggregated volume |
314,826 shares for NOK 31,482.6. | |||
| — Price |
||||
| e) | Date of the transaction | 2023-06-14 | ||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Sally Bennett | ||
| 2 | Reason for the notification | |||
| a) | Position/status | Board member, primary insider | ||
| b) | Initial notification/Amendment |
Initial notification | ||
| 3 | Details of issuer | |||
| a) | Name | BerGenBio ASA | ||
| b) | LEI | 213800TYYFXKYF3V2A23 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument Identification code |
Warrants (ISIN NO0012921495) | ||
| b) | Nature of the transaction | Receipt/accept of warrants (ISIN NO0012921495) to shares in BerGenBio ASA (ISIN NO0010650013). |
||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| 0 | 157,413 | |||
| d) | Aggregated information | |||
| — Aggregated volume |
157,413 warrants for NOK 0. | |||
| — Price |
||||
| e) | Date of the transaction | 2023-06-14 | ||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Debra Barker | ||
| 2 | Reason for the notification | |||
| a) | Position/status | Board member, primary insider | ||
| b) | Initial notification/Amendment |
Initial notification | ||
| 3 | Details of issuer | |||
| a) | Name | BerGenBio ASA | ||
| b) | LEI | 213800TYYFXKYF3V2A23 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument Identification code |
Shares in BerGenBio ASA (ISIN NO0010650013) | ||
| b) | Nature of the transaction | Allocated offer shares in the rights issue of BerGenBio ASA. | ||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| 0.10 | 311,027 | |||
| d) | Aggregated information | |||
| — Aggregated volume |
311,027 shares for NOK 31,102.7. | |||
| — Price |
||||
| e) | Date of the transaction | 2023-06-14 | ||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Debra Barker | ||
| 2 | Reason for the notification | |||
| a) | Position/status | Board member, primary insider | ||
| b) | Initial notification/Amendment |
Initial notification | ||
| 3 | Details of issuer | |||
| a) | Name | BerGenBio ASA | ||
| b) | LEI | 213800TYYFXKYF3V2A23 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument Identification code |
Warrants (ISIN NO0012921495). | ||
| b) | Nature of the transaction | Receipt/accept of warrants (ISIN NO0012921495) to shares in BerGenBio ASA (ISIN NO0010650013). |
||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| 0 | 155,513 | |||
| d) | Aggregated information | |||
| — Aggregated volume |
155,513 warrants for NOK 0. | |||
| — Price |
||||
| e) | Date of the transaction | 2023-06-14 | ||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Sarsia Development AS | ||
| 2 | Reason for the notification | |||
| a) | Position/status | Closely associated person of primary insider Sveinung Hole, board member in BerGenBio ASA. |
||
| b) | Initial notification/Amendment |
Initial notification | ||
| 3 | Details of issuer | |||
| a) | Name | BerGenBio ASA | ||
| b) | LEI | 213800TYYFXKYF3V2A23 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument Identification code |
Shares in BerGenBio ASA (ISIN NO0010650013). | ||
| b) | Nature of the transaction | Allocated offer shares in the rights issue of BerGenBio ASA | ||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| 0.10 | 33,500,000 | |||
| d) | Aggregated information — Aggregated volume — Price |
33,500,000 shares for NOK 3,350,000. | ||
| e) | Date of the transaction | 2023-06-14 | ||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Sarsia Development AS | ||
| 2 | Reason for the notification | |||
| a) | Position/status | Closely associated person of primary insider Sveinung Hole, board member in BerGenBio ASA. |
||
| b) | Initial notification/Amendment |
Initial notification | ||
| 3 | Details of issuer | |||
| a) | Name | BerGenBio ASA | ||
| b) | LEI | 213800TYYFXKYF3V2A23 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument Identification code |
Warrants (ISIN NO0012921495). | ||
| b) | Nature of the transaction | Receipt/accept of warrants (ISIN NO0012921495) to shares in BerGenBio ASA (ISIN NO0010650013). |
||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| 0 | 16,750,000 | |||
| d) | Aggregated information — Aggregated volume — Price |
16,750,000 warrants for NOK 0. | ||
| e) | Date of the transaction | 2023-06-14 | ||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Sarsia Seed AS | ||
| 2 | Reason for the notification | |||
| a) | Position/status | Closely associated person of primary insider Sveinung Hole, board member in BerGenBio ASA. |
||
| b) | Initial notification/Amendment |
Initial notification | ||
| 3 | Details of issuer | |||
| a) | Name | BerGenBio ASA | ||
| b) | LEI | 213800TYYFXKYF3V2A23 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument Identification code |
Shares in BerGenBio ASA (ISIN NO0010650013) | ||
| b) | Nature of the transaction | Allocated offer shares in the rights issue of BerGenBio ASA. | ||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| 0.10 | 8,100,000 | |||
| d) | Aggregated information — Aggregated volume — Price |
8,100,000 shares for NOK 810,000. | ||
| e) | Date of the transaction | 2023-06-14 | ||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Sarsia Seed AS | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | BerGenBio ASA. | Closely associated person of primary insider Sveinung Hole, board member in | ||
| b) | Initial notification/Amendment |
Initial notification | |||
| 3 | Details of issuer | ||||
| a) | Name | BerGenBio ASA | |||
| b) | LEI | 213800TYYFXKYF3V2A23 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
| a) | Description of the financial instrument, type of instrument Identification code |
Warrants (ISIN NO0012921495). | |||
| b) | Nature of the transaction | Receipt/accept of warrants (ISIN NO0012921495) to shares in BerGenBio ASA (ISIN NO0010650013). |
|||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| 0 | 4,050,000 | ||||
| d) | Aggregated information — Aggregated volume — Price |
4,050,000 warrants for NOK 0. | |||
| e) | Date of the transaction | 2023-06-14 | |||
| f) | Place of the transaction | Outside a trading venue |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.